| Literature DB >> 28825447 |
Abstract
Epilepsy, characterized by spontaneous recurrent seizures (SRS), is a serious and common neurological disorder afflicting an estimated 1% of the population worldwide. Animal experiments, especially those utilizing small laboratory rodents, remain essential to understanding the fundamental mechanisms underlying epilepsy and to prevent, diagnose, and treat this disease. While much attention has been focused on epileptogenesis in animal models of epilepsy, there is little discussion on SRS, the hallmark of epilepsy. This is in part due to the technical difficulties of rigorous SRS detection. In this review, we comprehensively summarize both genetic and acquired models of SRS and discuss the methodology used to monitor and detect SRS in mice and rats.Entities:
Keywords: Animal model; Epilepsy; Spontaneous recurrent seizures
Mesh:
Year: 2017 PMID: 28825447 PMCID: PMC5571473 DOI: 10.24272/j.issn.2095-8137.2017.042
Source DB: PubMed Journal: Zool Res ISSN: 2095-8137
Figure 1Schematic of video-EEG recording and EEG analyses
SRS in transgenic models of epilepsy
| Gene | Modification | Latency | Frequency and features of SRS | References |
| *: model or strain dependent phenotype; ECS: editing site complementary sequence; OE: overexpression; SRS: spontaneous recurrent seizures; SUDEP: sudden unexpected death in epilepsy; SWD: spike-wave discharges. | ||||
| P9 | Generalized convulsive SRS. SUDEP at P15 | |||
| P21–P27 | EEG and/or behavioral SRS lasted 20 s. Sporadic SUDEP from P21* | |||
| N/A | 12 out of 23 mice exhibited behavioral SRS (3 times/day, lasted 35 s). Lifespan of P33 | |||
| N/A | 2 out of 6 mice exhibited behavioral and/or EEG SRS | |||
| P12–P16 | Multiple tonic-clonic SRS/day confirmed by EEG (lasted 1–3 min, interval: 1–4 hr). SUDEP by P21 | |||
| P18 | Sporadic SUDEP in 1–3 mo* | |||
| P16 | Behavioral SRS lasted 30–90 s. SUDEP P16–P26 | |||
| N/A | 2 out of 14 mice exhibited 21 SRS in total during 96 h EEG recording | |||
| 2 mo* | EEG and behavioral SRS. Frequency and duration of SRS increased with age* | |||
| N/A | SWD with behavioral arrest* | |||
| 3 wk | No SRS prior to day of SUDEP 3 wk. SRS lasted <1 min | |||
| 8–16 wk | 0–3 SRS/day. SRS lasted <1 min. SUDEP 14 wk | |||
| 8 wk | As many as 25 SRS/day. SUDEP 9 wk | |||
| P10 | EEG and behavioral SRS at random intervals with duration from seconds to minutes. SUDEP 3 wk | |||
| P24 | Generalized EEG and behavioral SRS. SUDEP P16–P32* | |||
| 2 wk | Generalized EEG and behavioral SRS. SUDEP P0–P73* | |||
| 3 wk | Behavioral SRS lasted 20 s–2 min once or twice/hr throughout adult life. SUDEP 3–5 wk | |||
| N/A | Tonic-clonic SRS. SUDEP at P17 | |||
| N/A | Generalized EEG seizures without overt behavioral manifestation | |||
| Deletion (α1A−/−) | N/A | Absence seizures. SUDEP 3–4 wk | ||
| P12 | Behavioral SRS (once/4 hr). SUDEP by P20 | |||
| N/A | SRS with high-amplitude, low-frequency cortical EEG activity, prominent theta and delta waves | |||
| P20 | Behavioral arrest and associated SWD*
| |||
| 2–3 wk | Generalized tonic-clonic SRS. Few SRS at 3 wk, frequency increased over time. SUDEP 7–10 wk | |||
| P15 | Behavioral and EEG SRS. Frequency and duration varied by animal | |||
| P10 | Clonic SRS (1.6 seizures/hr at P14). SUDEP at P20 | |||
| N/A | <40% rats exhibited generalized SRS and/or absence seizures | |||
| N/A | 65% exhibited SRS, 10%–15% mortality at any age but peak around 3–4 mo | |||
| N/A | Spontaneous nonconvulsive seizure activity. Occurrence of SUDEP | |||
| P18 | SWD accompanied by behavioral immobility or tonic-clonic SRS* | |||
| 5 wk N/A | Spontaneous rhythmic EEG activity including SWD* Spontaneous behavioral myoclonic jerks | |||
| N/A | Hyperexcitability discharges accompanied by EEG SRS | |||
| 6 mo | SRS with generalized interictal spike discharges | |||
| <9 mo | 80% exhibited myoclonic SRS, more frequent during dark cycle | |||
| 3 mo | Recurrent tonic-clonic seizures or absence seizures* | |||
| 6–8 wk | Lifetime behavioral arrest and forelimb myoclonus (6.2 SRS/7 hr) | |||
SRS in acquired models of epilepsy
| Insult | Methods | Features | ||
| *: model or strain dependent phenotype; SE: status epilepticus; TBI: traumatic brain injury; KA: Kainic acid; DSP-4: N-(2-Chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride; TLE: temporal lobe epilepsy; SRS: spontaneous recurrent seizures; BLA: basolateral amygdala; AB: angular bundle: CCI: controlled cortical impact; LFP: lateral fluid percussion. | ||||
| SE | Pilocarpine (in the presence or absence of lithium) | Systemic or intracerebral injection | High mortality in general and wide spread brain damage* | |
| Kainic acid (KA) | Systemic or intracerebral injection | Hippocampal restricted damage. Short latent period (e.g., 3–5 days, KA amygdala infusion in mouse) | ||
| Bicuculine after a lesion induced by DSP-4 | Microinjection into anterior piriform cortex of rat | 30% developed SRS with mossy fiber sprouting | ||
| Tetanus toxin | Unilateral intrahippocampal injection in P10 rat | Early-life brain insult triggered diverse epileptiform response in adult rats | ||
| Febrile seizures | Hyperthermia in P10 rat | Mimic etiology of TLE. 35.2% rats developed SRS in adults | ||
| Sustained electrical stimulation | In BLA or AB of rat | Overall 80% (BLA) and 67% (AB) rats developed SRS | ||
| TBI | CCI or LFP | <50% developed SRS following TBI with long latent period* | ||
| Ischemia/hypoxia | Unilateral carotid ligation with hypoxia in P7 rat or global hypoxia in P10 rat | 100% rats developed SRS, which propagated along time | ||
| Methylazoxymethanol | In utero exposure | 2 out of 11 rats developed SRS | ||
| Virus infection | Intracerebral infection with Theiler’s murine encephalomyelitis virus | 75% mice developed seizures 3–10 days post infection* | ||
| Kindling | Over electrical kindling | Repeated daily electrical stimulus for weeks and months | Labor intensive, SRS have not been well characterized | |
| Flurothyl kindling | Repeated flurothyl induced convulsive seizures for 8 days (once/day) | SRS were observed within the first week following flurothyl kindling then remitted* | ||